Jean‐Michel Livrozet

Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study

Joseph J. Eron, Bonaventura Clotet, J. Durant et al. · The Journal of Infectious Diseases · 2012 · 312 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

A highly virulent variant of HIV-1 circulating in the Netherlands

Chris Wymant, Daniela Bezemer, François Blanquart et al. · Science · 2022 · 75 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +14

Early control of HIV replication in primary HIV-1 infection treated with antiretroviral drugs and pegylated IFNα: results from the Primoferon A (ANRS 086) Study

Dominique Émilie, Marianne Burgard, Caroline Lascoux‐Combe et al. · AIDS · 2001 · 68 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Patterns of Hepatitis C Virus Transmission in Human Immunodeficiency Virus (HIV)–infected and HIV-negative Men Who Have Sex With Men

Christophe Ramière, Caroline Charre, Patrick Miailhes et al. · Clinical Infectious Diseases · 2019 · 61 citations

Life Sciences, Infectious Diseases, Microbiology +17

Triple Nucleoside Combination Zidovudine/Lamivudine/Abacavir versus Zidovudine/Lamivudine/Nelfinavir as First-Line Therapy in HIV-1-Infected Adults: A Randomized Trial

Sophie Matheron, Diane Descamps, François Boué et al. · Antiviral Therapy · 2003 · 50 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17